EXHIBIT 10.10

Exhibit 10.10

DISTRIBUTORSHIP AGREEMENT

THIS AGREEMENT, effective as of 11th of November, 2022 (“Effective Date”), entered into between:

**Firstlink **is authorized by **Cubebio **to represent the Export sales of the PRODUCT (as hereinafter defined) and to possess the right to grant the distributorship of the **PRODUCT **to the distributors in the Territory.

Whereas, the **Cubebio **appoints and names the Firstlink, and the **Firstlink **is willing to be appointed and named, as the **CUBEBIO’S **exclusive distributor of the **PRODUCT **in the **Territory **(as hereinafter defined) with the rights including but not limited to re-distribute or resell the **PRODUCTS **in the **Territory **and hold the licenses under the name of FIRSTLINK.

The parties agree as follows:

Subject to the terms and conditions of this Distributorship Agreement and the Appendixes hereunder (“this Agreement”), **Cubebio **appoints Firstlink, and **Firstlink **accepts such appointment and agrees to act as **CUBEBIO’S **exclusive distributor of the **CUBEBIO’S PRODUCTS **within the **Territory **(as defined below).

**CUBEBIO’S **appointment of **FIRSTLINK **in Appendix 1 of this Agreement is appointment to distribute **PRODUCT **in the **Territory **for a period of 3 years from November 11, 2022 to 30th October 2025. Firstlink shall advertise, solicit and make sales of the PRODUCTS, appoint sub-distributor for the **PRODUCTS **in the **Territory **to do any business activities that would cause direct or indirect competition with **Firstlink **in distributing the **PRODUCTS **within the Territory.

Taiwan, Thailand, Indonesia, Philippines, Vietnam and Malaysia.

See attached **PRODUCT **list. (Appendix I)

New items or territories may be further added in the attachment as a new Appendix later on when if mutually agreed by both **CUBEBIO **and **FIRSTLINK **in writing.

	2

	3

**CUBEBIO **shall manufacture and deliver the **PRODUCT **in strict conformance with the **PRODUCT’s **specifications according to approved registration file from time to time and, during the period of validity of the **PRODUCTS, CUBEBIO **shall be liable for the effectiveness of PRODUCT. FIRSTLINK shall not manufacture or distribute similar products by itself or through any other third party or appoint any other third party to manufacture the **PRODUCT **regardless of any circumstance.

	4

Either party shall be fully responsible for any damages arising from the breach of any obligation under this Agreement.

See attached Appendix I

Prices from **CUBEBIO **will always be fair and competitive. Only justified price corrections can be made based on the changes directly related to the production costs and currency fluctuations. In the event of any price changes, **CUBEBIO **shall give **FIRSTLINK **sixty (60) days of prior written notice and confirmed by **FIRSTLINK **in writing and keeping the same price for the last orders until the new price is in place.

The prices on clause (11) may be adjusted through discussion and by mutually written agreement in case of huge change of market conditions that is reasonably beyond the control by both parties.

	5

Both parties shall agree upon the definitive payment and delivery terms in writing in due course in respect of the **PRODUCT **having considered the registration progress, marketing plan and manufacturing progress.

**FIRSTLINK **shall have an inspection period of TEN (10) business days for goods inspection, Any superficial defective or damaged PRODUCT shall be reported to the **CUBEBIO **within three working days after the inspection period in writing. **CUBEBIO **shall arrange goods replacement for identified defective or damaged goods of quality issue at its own cost within mutually agreed period. Cargo return of unsold goods shall not be permitted after the inspection period under **CUBEBIO’s **cost, unless both parties agree on it due to the quality issue of the product.

The CUBEBIO:

The FIRSTLINK:

	6

Neither the **CUBEBIO **nor the **FIRSTLINK **shall be liable for damages for any delay or failure in the performance of this Agreement resulting from any cause beyond its reasonable control irrespective of the nature thereof and is not foreseeable on the Effective Date. Such cause shall include, without limitation, Acts of God, fires, explosions, floods, wars, acts of war, sabotage, riots accidents, breakdowns of machinery or equipment, plant shutdowns, strikes, labor disputes or shortages, all governmental actions and inability to obtain material equipment or transportation.

The party prevented from performing this Agreement because of an event of Force Majeure shall promptly notify the other party of the occurrence of such event together with a description thereof and an estimation of the length of the delay such event is likely to the performance of this Agreement. In the event that the performance of a party is delayed for more than [6 months], the other party shall have the right, which shall be exercisable for so long as the cause of such delay shall continue to exist, to terminate this Agreement without liability for such termination.

**CUBEBIO **shall have no right to assign any of its rights or delegate its obligations under this Agreement without prior written consent of FIRSTLINK. This Agreement shall be binding upon the parties’ respective successors and permitted assigns.

In the event that any provision of this Agreement shall be unenforceable or invalid under any applicable law or be so held by applicable court or arbitration decision, such unenforceability or invalidity shall not render this Agreement unenforceable or invalid as a whole, and, in such event, such provisions shall be changed and interpreted so as to best accomplish the objectives of such unenforceable or invalid provision within the limits of applicable law or applicable court or arbitration decision.

	7

with this contract, or the breach, termination or invalidity thereof, shall be finally settled by arbitration referred to Singapore International Arbitration Centre in accordance with its Practice Note on UNVITRAL cases. The language of arbitration shall be English. The arbitral award shall be final and binding upon both parties.

The attached “Appendixes” duly signed by both parties constitute part of this Agreement. This Agreement embodies the entire agreement between the parties with respect to the subject matter hereof.

No amendment, change, modification, nor alteration of the terms and conditions of this Agreement shall be binding upon either Party unless written and signed by the Parties.

In witness whereof, the parties have hereto caused this Agreement, to be executed in duplicate by their representatives as of the day, month and year herein under written in their registered office.

	8

[CUBEBIO Co., Ltd.]	** **	[Firstlink Healthcare Asia Ltd.]
** **	** **	** **
[Choi, Eun-Jong]	** **	[Patrick Wong]
[CEO]	** **	[CEO]
** **	** **	** **
11th November 2022	** **	11th November 2022

	9

Appendix I

PRODUCT Specification and Terms

Trade Term: FOB Korea

3-year sales forecast for sales by Territory

Taiwan

Thailand

	10

Indonesia

Philippines

Vietnam

Malaysia

	11